A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Internationally Acclaimed Vascular Surgeon Dr. Frank J Veith Joins ViTAA Medical Solutions Board

Frank J Veith, M.D.

ViTAA Medical Solutions, a leading innovator of precision vascular health designed to improve patient outcomes across the globe, is thrilled to announce the appointment of Frank J. Veith, M.D. a distinguished figure in the field of vascular surgery, to its Board of Directors.

Internationally Recognized Vascular Surgeon

With a career spanning several decades, Dr. Veith has earned international acclaim for his pioneering contributions to vascular surgery, particularly in the areas of limb salvage, lung transplantation, and endovascular treatments. His groundbreaking work includes performing the first endovascular aortic repair in North America, a milestone that has significantly influenced the direction and capabilities of modern vascular surgery. His leadership and expertise have also been instrumental in managing VEITHsymposium, one of the largest annual conferences regrouping vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists to learn the most current information about what is new and important in the treatment of vascular disease.

Mitchel Benovoy, CEO of ViTAA Medical Solutions

Mitchel Benovoy
Mitchel Benovoy, Chief Executive Officer At Vitaa Medical Solutions

“We are honored to welcome Dr. Veith to our Board of Directors. His unparalleled expertise, visionary leadership, and commitment to improving patient care align perfectly with ViTAA’s mission. We are confident that Dr. Veith’s guidance will be invaluable as we continue to innovate in the vascular health industry.”

Dr. Veith’s addition to the Board underscores ViTAA’s commitment to excellence and innovation in the development of medical technologies. His vast experience and achievements will provide critical insights and direction as ViTAA continues to pursue its goal of revolutionizing patient care through cutting-edge solutions.

Dr. Veith Comments

“I am honored and excited to join the ViTAA Board of Directors and contribute to their mission of transforming vascular care ” said Dr. Veith. “I look forward to working alongside a team that is as dedicated to advancing the field of vascular surgery as I have been throughout my career.”

About Dr. Frank J. Veith Frank J Veith, M.D., is Professor of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH and New York University Medical Center NY, NY. Additionally, Dr. Veith occupies The William J. von Liebig Chair in Vascular Surgery at the Cleveland Clinic Foundation. Dr. Veith graduated from Cornell University Medical School 1955, completed his residency at Peter Bent Brigham Hospital, Harvard Medical School 1956-63 and served as Captain, U.S. Army Medical Corps and Chief, Surgical Service, U.S. Army Hospital, Fort Carlson, Colorado 1960-62.

About ViTAA Medical Solutions: ViTAA is at the forefront of developing transformative vascular health technologies that aim to improve decision making through proprietary technology aimed at assessing vascular wall strength and weakness non-invasively. For more information, visit www.vitaamedical.com.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Julie Blasingim, formerly President, has over 20 years of experience in the clinical research industry.
John Witkowski served as President of DSM Biomedical, the global biomaterials division of dsm-firmenich, where he led a significant period of transformational growth.
Julia James served as Executive Vice President and General Counsel of PPD, the leading contract research organization, until its acquisition by Thermo Fisher Scientific in 2021. She then continued as General Counsel, Clinical Research, following the transaction.

By using this website you agree to accept Medical Device News Magazine Privacy Policy